DK362989A - Analoge af fibroblastvaekstfaktor - Google Patents

Analoge af fibroblastvaekstfaktor Download PDF

Info

Publication number
DK362989A
DK362989A DK362989A DK362989A DK362989A DK 362989 A DK362989 A DK 362989A DK 362989 A DK362989 A DK 362989A DK 362989 A DK362989 A DK 362989A DK 362989 A DK362989 A DK 362989A
Authority
DK
Denmark
Prior art keywords
analogue
growth factor
fibroblast growth
fibroblast
factor
Prior art date
Application number
DK362989A
Other languages
English (en)
Other versions
DK362989D0 (da
Inventor
Tsutomu Arakawa
Gary M Fox
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DK362989D0 publication Critical patent/DK362989D0/da
Publication of DK362989A publication Critical patent/DK362989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK362989A 1987-11-24 1989-07-21 Analoge af fibroblastvaekstfaktor DK362989A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12489687A 1987-11-24 1987-11-24
US27152188A 1988-11-17 1988-11-17

Publications (2)

Publication Number Publication Date
DK362989D0 DK362989D0 (da) 1989-07-21
DK362989A true DK362989A (da) 1989-09-25

Family

ID=26823063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK362989A DK362989A (da) 1987-11-24 1989-07-21 Analoge af fibroblastvaekstfaktor

Country Status (9)

Country Link
EP (1) EP0320148A1 (da)
JP (1) JPH02504468A (da)
KR (1) KR890701607A (da)
AU (1) AU638402B2 (da)
DK (1) DK362989A (da)
FI (1) FI893530L (da)
NZ (1) NZ227057A (da)
PT (1) PT89081B (da)
WO (1) WO1989004832A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
JP3130313B2 (ja) * 1989-12-19 2001-01-31 武田薬品工業株式会社 ヒトｂＦＧＦムテインの製造法
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
DE69119869T2 (de) * 1990-11-23 1996-12-12 American Cyanamid Co Chimeres Fibroblasten-Wachstumsfaktor
US5206354A (en) * 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
US6833354B1 (en) 1990-12-19 2004-12-21 Kaken Pharmaceutical Co., Ltd. Agent for the treatment of bone diseases
JP3135138B2 (ja) * 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
AU659723B2 (en) * 1992-02-14 1995-05-25 Kaken Pharmaceutical Co., Ltd. Remedy for airway diseases
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
AU7475694A (en) * 1993-08-02 1995-02-28 Prizm Pharmaceuticals, Inc. Monogenous preparations of cytotoxic conjugates
TW275068B (da) * 1993-09-24 1996-05-01 American Cyanamid Co
US6399386B1 (en) 1994-07-22 2002-06-04 President And Fellows Of Harvard College Method of isolating receptor and ligand DNA
US5766923A (en) * 1994-07-22 1998-06-16 President & Fellows Of Harvard College Isolated nucleic acid encoding ligands for FGFR
KR100374310B1 (ko) * 1995-02-14 2003-05-22 주식회사 엘지생명과학 변형된인간염기성섬유아세포성장인자및이의생산방법
WO1999055861A2 (en) * 1998-04-28 1999-11-04 Eisai Co., Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
US20030166550A1 (en) 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
JP2002527401A (ja) 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法
US6440934B1 (en) 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US20020072489A1 (en) 1998-10-13 2002-06-13 Whitehouse Martha J. Angiogenically effective unit dose of FGF-2 and method of use
JP5704780B2 (ja) 1999-08-13 2015-04-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 脈管形成因子の用量および心筋血流を改善するための投与方法
HUE025872T2 (en) 2002-06-18 2016-05-30 Eisai R&D Man Co Ltd Primary, cultured adipocytes for gene therapy
WO2005087257A1 (ja) * 2004-03-16 2005-09-22 Kaken Pharmaceutical Co., Ltd. 架橋ゼラチンゲルを担体とする軟骨組織修復治療剤
CN108324928B (zh) * 2018-03-05 2020-09-08 哈尔滨医科大学 重组人成纤维细胞生长因子-5在促骨折愈合中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296100A (en) * 1980-06-30 1981-10-20 Franco Wayne P Method of treating the heart for myocardial infarction
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
EP0593065B1 (en) * 1985-09-12 2002-08-21 Scios Inc. Recombinant fibroblast growth factors

Also Published As

Publication number Publication date
EP0320148A1 (en) 1989-06-14
JPH02504468A (ja) 1990-12-20
AU2818189A (en) 1989-06-14
PT89081B (pt) 1993-09-30
FI893530A7 (fi) 1989-07-21
FI893530A0 (fi) 1989-07-21
PT89081A (pt) 1989-11-30
DK362989D0 (da) 1989-07-21
AU638402B2 (en) 1993-07-01
NZ227057A (en) 1990-12-21
WO1989004832A1 (en) 1989-06-01
FI893530L (fi) 1989-07-21
KR890701607A (ko) 1989-12-21

Similar Documents

Publication Publication Date Title
DK362989D0 (da) Analoge af fibroblastvaekstfaktor
DK2490D0 (da) Rekombinante fibroblastvaekstfaktorer
FI920027A7 (fi) Fibroblastikasvutekijöiden reseptoreita
FI921428A7 (fi) Menetelmä emäksisen fibroblastikasvutekijän entsymaattiseksi valmistam iseksi
FR2605214B1 (fr) Prothese perihepatique
DK0410711T3 (da) Protese
DK510388D0 (da) Produktion af en fibroblast-vaekstfaktor
NO173485C (no) Resorberbar protese
DE69125659D1 (de) Modifikation der Kristallzüchtung
FR2617040B1 (fr) Prothese cotyloidienne
FI902391A7 (fi) Ihmisen/naudan emäksisen fibroblastikasvutekijän uudet johdannaiset
DK539587D0 (da) Faktor viii-c analoge
DK62589A (da) Kloning og ekspression af human vaekstfaktor
FR2611486B1 (fr) Prothese uretrale
DE3890771T1 (de) Intraokularlinse zur korrektion von ametropie
DK116390D0 (da) Accellerering af knogledannelse med gm-csf
DE69314443D1 (de) Analoge multifunktionsuhr mit abnehmbarem teilstück
KR880019015U (ko) 분리식 하지구
FR2610822B1 (fr) Prothese de hanche
KR900701835A (ko) Crf 유사체
FI923863L (fi) Crf-analoger
DK420185D0 (da) Anvendelse af somatostatinanaloge
FI942467A7 (fi) Proteesivakaat proteiinit
DK472189A (da) Vaeksthormon
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment